IL33 in rheumatoid arthritis: potential contribution to pathogenesis

ABSTRACT A better understanding of the inflammatory mechanisms of rheumatoid arthritis and the development of biological therapy revolutionized its treatment, enabling an interference in the synovitis – structural damage – functional disability cycle. Interleukin 33 was recently described as a new m...

Full description

Bibliographic Details
Main Authors: Rafaela Bicalho Viana Macedo, Adriana Maria Kakehasi, Marcus Vinicius Melo de Andrade
Format: Article
Language:English
Published: Sociedade Brasileira de Reumatologia
Series:Revista Brasileira de Reumatologia
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0482-50042016000500451&lng=en&tlng=en